Taliglucerase alfa - Pfizer/Protalix Biotherapeutics
At a glance
- Drug Originator Protalix Biotherapeutics
- Drug Licenced by Pfizer
- Drug Class Glucosidases; Recombinant proteins
- Mechanism of Action Glucosylceramidase replacements
- USA Patent Applicants PFIZER
- USA Patents 5
- BLAs 1
- International Patents 13

Disclaimer